Colorectal Cancer: Prevention and Management of Metastatic Disease

被引:42
|
作者
Sugarbaker, Paul H. [1 ]
机构
[1] Washington Canc Inst, Washington, DC 20010 USA
关键词
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PERITONEAL CARCINOMATOSIS; CYTOREDUCTIVE SURGERY; SYSTEMIC CHEMOTHERAPY; SURGICAL-TREATMENT; RANDOMIZED-TRIAL; ADJUVANT THERAPY; MITOMYCIN-C; HIGH-RISK; LIVER;
D O I
10.1155/2014/782890
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This paper compared the similarities and differences of the two most common types of colorectal cancer metastases. The treatment of liver metastases by surgery combined with systemic chemotherapy was explained. The different natural history of liver metastases as compared to peritoneal metastases and the possibility for prevention of peritoneal metastases were emphasized. Perioperative cancer chemotherapy or second-look surgery must be considered as individualized treatments of selected patients who have small volume peritoneal metastases or who are known to be at risk for subsequent disease progression on peritoneal surfaces. However, the fact that peritoneal metastases, when diagnosed in the follow-up of colorectal cancer patients, can be cured with a combination of cytoreductive surgery and hyperthermic perioperative chemotherapy cannot be ignored. Careful follow-up and timely intervention in colorectal cancer patients with progressive disease are a necessary part of the management strategies recommended by the multidisciplinary team. After a critical evaluation of the data currently available, these strategies for prevention and management of colorectal metastases are presented as the author's recommendations for a high standard of care. As more information becomes available, modifications may be necessary.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The Role of Curcumin in Prevention and Management of Metastatic Disease
    Bachmeier, Beatrice E.
    Killian, Peter H.
    Melchart, Dieter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06):
  • [22] Regorafenib for Metastatic Colorectal Cancer Common Toxicities and Prevention Strategies
    Draper, Amber
    ONCOLOGY-NEW YORK, 2019, 33 (04): : 126 - 127
  • [23] Advancements in Cervical Cancer Prevention and Management of Persistent, Recurrent, and Metastatic Disease: 2016 Update
    Fuentes, Alejandra
    Garcia, Agustin A.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (12) : 8 - 17
  • [24] Aspirin and the prevention of a common disease: Colorectal cancer
    Andreotti, Felicita
    De Caterina, Raffaele
    Crea, Filippo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 394 - 395
  • [26] Arfolitixorin: An unmet need in the management of metastatic colorectal cancer
    Sadiq, Mahnoor
    Ibtehaj-ul-Haque
    Ashraf, Muhammad Moin
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (05) : 1027 - 1027
  • [27] Management of chemotherapy dose intensity for metastatic colorectal cancer
    Chu, Xuelei
    Xue, Peng
    Zhu, Shijie
    ONCOLOGY LETTERS, 2022, 23 (05)
  • [28] Editorial: Future frontiers in the management of metastatic colorectal cancer
    Giovinazzo, Francesco
    Gallo, Gaetano
    Goglia, Marta
    Pavone, Matteo
    Coppola, Alessandro
    Dell'Aquila, Emanuela
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [29] Optimal Management of Metastatic Colorectal Cancer Current Status
    McRee, Autumn J.
    Goldberg, Richard M.
    DRUGS, 2011, 71 (07) : 869 - 884
  • [30] NCCN Guidelines Updates: Management of Metastatic Colorectal Cancer
    Messersmith, Wells A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (05): : 599 - 601